VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NHTC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NHTCNatural Health Trends Corp.
$1.59$18M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNHTCFinancials

Natural Health Trends Corp. (NHTC) Financials

30Y historyFree accessUpdated daily

Revenue has entered a consistent downward trend, culminating in a 14.3% year-over-year decline in 2026Q1 while operating margins deteriorated to -5.1%.

NHTC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue38.24M39.78M42.96M43.92M49.13M60.01M62.07M77.61M191.91M197.56M287.73M264.86M124.59M52.53M37.51M31.16M23.58M30.74M45.81M76.5M133.43M194.47M133.22M62.89M39.66M24.79M8.32M15.27M1.19M6.99M7.22M
Revenue Growth %-10.54%-7.42%-2.19%-10.6%-18.12%-3.33%-20.03%-59.56%-2.86%-31.34%8.63%112.59%137.19%40.02%20.38%32.18%-23.31%-32.89%-40.12%-42.66%-31.39%45.97%111.85%58.55%59.97%198%-45.51%1181.96%-82.97%-3.14%-
Cost of Goods Sold10.01M10.52M11.18M11.18M12.66M15.01M16.99M20.1M39.37M38.65M54.9M54.1M26.98M12.55M9.69M8.17M6.97M9.53M12.68M20.29M33.07M44.75M29.32M12.52M7.39M5.88M2.05M4.27M454.37K2.87M4.44M
COGS % of Revenue-26.46%26.02%25.44%25.77%25.01%27.37%25.9%20.51%19.56%19.08%20.43%21.66%23.89%25.82%26.22%29.56%30.99%27.68%26.52%24.78%23.01%22.01%19.92%18.64%23.7%24.59%27.94%38.15%41.02%61.54%
Gross Profit28.24M29.25M31.79M32.75M36.47M44.99M45.08M57.51M152.54M158.92M232.82M210.76M97.61M39.98M27.83M22.99M16.61M21.21M33.13M56.21M100.36M149.73M103.9M50.36M32.27M18.92M6.27M11M736.75K4.12M2.78M
Gross Margin %73.84%73.54%73.98%74.56%74.23%74.99%72.63%74.1%79.49%80.44%80.92%79.57%78.34%76.11%74.18%73.78%70.44%69.01%72.32%73.48%75.22%76.99%77.99%80.08%81.36%76.3%75.41%72.06%61.85%58.98%38.46%
Gross Profit Growth %--7.97%-2.94%-10.21%-18.94%-0.19%-21.61%-62.3%-4.01%-31.74%10.47%115.92%144.17%43.65%21.05%38.44%-21.72%-35.96%-41.07%-43.99%-32.97%44.1%106.32%56.06%70.58%201.51%-42.97%1393.39%-82.14%48.56%-
Operating Expenses30.15M31.06M33.08M34.42M36.74M43.42M44.41M64.53M118.81M115.86M168.69M162.88M76.79M35.75M25.18M21.21M19.69M26.8M36.28M81.44M112.59M152.78M101.68M-6.16M28.77M17.64M18.46M18.12M3.28M8.18M3.43M
OpEx % of Revenue-78.09%77.01%78.36%74.78%72.37%71.55%83.15%61.91%58.64%58.63%61.5%61.63%68.07%67.13%68.05%83.5%87.18%79.2%106.45%84.39%78.56%76.32%-9.8%72.54%71.13%221.89%118.67%275.12%116.98%47.58%
Selling, General & Admin30.15M31.06M33.08M34.42M36.74M43.42M44.41M62.77M118.81M115.86M168.29M162.62M76.68M35.69M25.14M20.91M18.47M25.48M34.82M69.62M114M152.78M101.68M43.84M28.77M17.64M18.46M7.72M3.28M7.64M3.41M
SG&A % of Revenue-78.09%77.01%78.36%74.78%72.37%71.55%80.87%61.91%58.64%58.49%61.4%61.55%67.94%67.01%67.1%78.36%82.89%76.02%91%85.44%78.56%76.32%69.71%72.54%71.13%221.89%50.58%275.12%109.22%47.28%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses00000001.76M789K367K-59K-84K-184K-32K-39K298K1.21M1.32M1.46M11.82M-1.41M00-50M00010.4M0543.21K22K
Operating Income-1.94M-1.81M-1.3M-1.67M-270K1.57M669K-7.02M33.73M43.06M64.14M47.88M20.82M4.22M2.65M1.78M-3.08M-5.59M-3.18M-25.22M-12.23M-3.05M2.22M56.52M3.5M1.28M-12.55M-7.12M-2.54M-4.06M-658.43K
Operating Margin %-5.06%-4.55%-3.02%-3.8%-0.55%2.62%1.08%-9.05%17.58%21.8%22.29%18.08%16.71%8.04%7.05%5.72%-13.06%-18.18%-6.95%-32.97%-9.17%-1.57%1.67%89.88%8.83%5.17%-150.86%-46.61%-213.27%-58%-9.12%
Operating Income Growth %--39.18%22.26%-518.89%-117.19%134.83%109.53%-120.82%-21.66%-32.86%33.96%129.96%393.01%59.66%48.35%157.91%44.9%-75.61%87.39%-106.2%-300.56%-237.38%-96.07%1514.43%173.09%110.21%-76.36%-180.17%37.36%-515.97%-
EBITDA-1.65M-1.7M-1.17M-1.51M-66K1.87M1.08M-6.64M34.16M43.59M64.53M48.14M20.93M4.29M2.69M2.08M-1.87M-4.27M-1.73M-23.37M-10.12M-1.58M3.52M57.06M3.97M1.37M-12.19M-6.74M-1.99M-3.49M-413.86K
EBITDA Margin %-4.31%-4.27%-2.72%-3.43%-0.13%3.12%1.74%-8.55%17.8%22.07%22.43%18.18%16.8%8.17%7.17%6.68%-7.91%-13.89%-3.77%-30.55%-7.59%-0.81%2.64%90.73%10.01%5.54%-146.48%-44.16%-167.12%-49.88%-5.73%
EBITDA Growth %-42.84%-45.46%22.5%-2183.33%-103.53%73.31%116.26%-119.43%-21.65%-32.44%34.05%130.06%387.88%59.44%29.26%211.52%56.29%-147.33%92.62%-130.9%-540.7%-144.9%-93.83%1336.86%189.28%111.26%-80.74%-238.74%42.93%-742.81%-
D&A (Non-Cash Add-back)68K109K131K164K204K299K410K387K424K536K394K263K105K66K45K298K1.21M1.32M1.46M1.85M2.11M1.47M1.3M531.94K469.7K90.58K364.4K374.15K549.67K567.67K244.57K
EBIT-1.51M-567K-1.3M-1.67M-270K1.57M669K-5.26M34.52M43.43M64.14M47.79M20.64M4.19M2.65M1.78M-2.48M-3.91M-984K-25.22M-12.23M-3.3M2.22M5.58M238K1.28M-12.19M-7.12M-2.54M-4.1M-658.43K
Net Interest Income000000000000000-11K-9K-2.52M-2.32M000000000000
Interest Income0000000000000005K9K36K107K000000000000
Interest Expense00000000000000016K18K2.55M2.42M000004.1M1.2M00000
Other Income/Expense1.07M1.24M1.92M2.42M872K-61K821K1.43M789K367K-59K-84K-184K-32K-39K344K583K-875K-226K143K946K-277K137K-1K-199K-79.95K9.08K-67.18K1.25M-1.14M-231.11K
Pretax Income-866K-567K620K745K602K1.51M1.49M-5.6M34.52M43.43M64.08M47.79M20.64M4.19M2.61M2.13M-2.5M-6.46M-3.41M-25.08M-11.29M-3.96M2.36M6.24M4.1M1.2M-10.67M-7.25M-1.29M-5.2M-889.54K
Pretax Margin %-2.26%-1.43%1.44%1.7%1.23%2.52%2.4%-7.21%17.99%21.98%22.27%18.04%16.56%7.98%6.95%6.83%-10.59%-21.02%-7.44%-32.79%-8.46%-2.04%1.77%9.92%10.34%4.85%-128.24%-47.5%-108.13%-74.37%-12.32%
Income Tax292K315K48K177K289K425K647K14K3.49M19.85M8.99M552K266K102K-24K-298K-27K-78K456K200K182K1.59M663K860K-4.1M-1.2M10.67M7.25M1.29M2.52M0
Effective Tax Rate %-33.72%-55.56%7.74%23.76%48.01%28.15%43.42%-0.25%10.1%45.71%14.03%1.15%1.29%2.43%-0.92%-14.01%1.08%1.21%-13.38%-0.8%-1.61%-40.04%28.09%13.79%-100%-100%-100%-100%-100%-48.54%0%
Net Income-1.16M-882K572K568K313K1.08M843K-5.61M31.04M23.58M55.09M47.24M20.37M4.09M2.63M2.31M-2.45M-6.34M-3.86M-25.29M-11.46M-5.5M1.24M5.38M4.1M1.2M-10.67M-7.25M-1.29M-7.73M-889.54K
Net Margin %-3.03%-2.22%1.33%1.29%0.64%1.81%1.36%-7.23%16.17%11.93%19.15%17.84%16.35%7.78%7.01%7.4%-10.38%-20.63%-8.44%-33.05%-8.59%-2.83%0.93%8.55%10.34%4.85%-128.24%-47.5%-108.13%-110.48%-12.32%
Net Income Growth %-328.85%-254.2%0.7%81.47%-71.15%28.71%115.02%-118.08%31.63%-57.2%16.61%131.91%398.17%55.48%14.1%194.16%61.4%-64.13%84.72%-120.65%-108.29%-543.35%-76.93%31.12%241.23%111.27%-47.1%-463.14%83.33%-768.44%-
Net Income (Continuing)-1.16M-882K572K568K313K1.08M843K-5.61M31.04M23.58M55.09M47.24M20.37M4.09M2.63M2.42M-2.47M-6.38M-3.86M-25.29M-11.46M-4.92M1.24M4.73M-261K2.02M-12.8M-7.56M-2.74M-4.3M-889.54K
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000-93K-7K34K33K22K77K598K710.96K726.75K000000
EPS (Diluted)-0.11-0.080.050.050.030.100.07-0.522.742.094.833.821.610.360.230.21-0.23-0.63-0.40-2.96-1.42-0.790.180.83-11.00-98.00-111.27-100.28-58.27-805.12-0.32
EPS Growth %-332.95%-254.02%0.4%81.02%-71.16%28.73%114.19%-118.98%31.1%-56.73%26.44%137.27%347.22%56.52%9.52%191.3%63.49%-57.5%86.49%-108.45%-79.75%-538.89%-78.31%107.55%88.78%11.93%-10.96%-72.1%92.76%-251500%-
EPS (Basic)--0.080.050.050.030.100.08-0.522.752.104.843.841.670.360.240.21-0.23-0.63-0.40-2.96-1.42-0.790.221.030.600.44-111.27-100.28-58.27-805.12-0.32
Diluted Shares Outstanding10.14M11.5M11.49M11.46M11.42M11.42M11.42M10.87M11.32M11.27M11.41M12.37M12.6M11.33M11.23M10.82M10.51M10.14M9.68M8.55M8.08M6.93M6.82M5.69M2.9M1.07M95.89K72.33K22.1K9.6M2.8M
Basic Shares Outstanding10.14M11.5M11.47M11.44M11.36M11.02M10.63M10.87M11.3M11.25M11.38M12.3M12.13M11.15M10.94M10.7M10.51M10.14M9.68M8.55M8.08M6.93M5.58M4.61M2.9M1.07M95.89K72.33K22.1K9.6M2.8M
Dividend Payout Ratio--1610.66%1622.36%2919.49%842.21%1083.99%-101.54%73.03%12.51%3.62%2.34%------------------

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowDeteriorating
Top Statement Risk

Distributor network collapse risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Persistent Revenue Erosion Trends

As reported in recent financial filings, NHTC's revenue has experienced a consistent downward trajectory, culminating in a 14.3% year-over-year decline in 2026Q1, which suggests that the company is struggling to maintain its core distributor base within the highly competitive Greater China wellness market.

The persistent contraction in top-line performance indicates that the company's multi-level marketing model is failing to attract new participants at a rate sufficient to offset churn. This trend appears to reflect a broader loss of momentum in the company's primary geographic hubs, potentially exacerbated by shifting regulatory sentiment.

Operating Leverage Turning Negative

Based on the provided income statement data, NHTC's operating margin has deteriorated to -5.1% in 2026Q1, demonstrating that the company's fixed corporate overhead is no longer being adequately absorbed by the shrinking revenue base, leading to a clear deleveraging effect on the bottom line.

The inability to scale SG&A expenses in proportion to declining sales suggests that the company's cost structure is becoming increasingly rigid. Investors should monitor whether management can implement meaningful cost-cutting measures, as the current operating loss trajectory appears unsustainable without a significant reversal in sales volume.

Resilient Gross Margins Masking Weakness

According to historical income statements, NHTC has maintained a robust gross margin profile, consistently hovering around 73-75%, which suggests that the underlying product pricing power remains intact despite the significant volume declines observed across the company's primary wellness and beauty product segments.

While the high gross margin is characteristic of the direct-selling industry, it fails to compensate for the rising relative burden of fixed operating expenses. This divergence between strong gross profitability and negative operating income highlights that the company's primary challenge is not product pricing, but rather the loss of operational scale.

Structural Risks to Business Viability

As indicated by the recent shift to consistent quarterly operating losses, the company faces a critical inflection point where its cash reserves of $6.8M may prove insufficient to sustain operations if the current negative revenue growth trend continues to erode the firm's liquidity position.

Short-term observers might focus on the company's debt-free status as a safety net, yet the lack of meaningful cash flow generation suggests that the business model is currently consuming capital rather than creating it. The reliance on a single, concentrated geographic market further compounds the risk that any localized regulatory or economic shock could lead to a rapid depletion of remaining assets.

NHTC — Frequently Asked Questions

Quick answers to the most common questions about buying NHTC stock.

What was Natural Health Trends Corp.'s (NHTC) revenue in 2025?

For fiscal year 2025, Natural Health Trends Corp. (NHTC) reported total revenue of $39.8M. This represents a 451.0% increase compared to $7.2M in 1996.

Is Natural Health Trends Corp. (NHTC) profitable?

Natural Health Trends Corp. (NHTC) reported a net loss of $0.9M for the fiscal year ending 2025.

What is Natural Health Trends Corp.'s operating profit margin?

Natural Health Trends Corp. (NHTC) reported an operating income of $-1.8M, resulting in an operating profit margin of -4.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Natural Health Trends Corp.'s gross profit and gross margin?

Natural Health Trends Corp. (NHTC) generated $29.3M in gross profit for the year, representing a gross profit margin of 73.5%. This demonstrates the company's core pricing power and production efficiency.